Baxter International Inc. · NYSE:BAX
Baxter International — Baxter's 2022 Investor Conference
9 slides from Baxter International's conference presentation, May 25, 2022
Slide 1: Advanced Surgery
ADVANCED SURGERY GIUSEPPE ACCOGLI Executive VP and Chief Operating Officer
Slide 2: Forward-Looking Statements
Forward-Looking Statements The presentations being made on May 25, 2022 include forward-looking statements concerning Baxter’s financial results, R&D pipeline, including planned product launches (many of which are subject to regulatory approval and may require additional investment) and results of c
Slide 3: Advanced Surgery: Who We Are
Advanced Surgery: Who We Are Partnering with the surgical community to provide the right product for the right clinical need • Addressing 14+ surgical specialties • Driving clinician confidence • Helping enhance clinical outcomes • Advancing product features to increase surgical efficiencies 65
Slide 4: Global Market Expected To Grow 3% - 4% Through 2025
Global Market Expected To Grow 3% - 4% Through 2025 ~$3.9B Market Dynamics CAGR 3% - 4% ~$3.5B ~$0.3B Opportunities ~$0.2B Microsurgery 8% - 9% • Providing cost effective, clinically-proven surgical solutions to improve surgical efficiencies • Increased patient complexity underscoring the Hemostats,
Slide 5: Market-Leading Portfolio
Market-Leading Portfolio Hemostats & Sealants Microsurgery Hemostatic products to stop various grades of Leading microsurgery tools and systems for use bleeding and sealants to close the wounds and in plastic reconstructive, head & neck, hand seal areas of weaknesses Hemostats & Sealants extremity,
Slide 6: Strategy To Drive Above-Market Growth Of 4% - 5% Through 2025
Strategy To Drive Above-Market Growth Of 4% - 5% Through 2025 Innovation Market Expansion Operational Efficiency Core Therapies: Market Development: Drive Efficiencies: • Extend product utilization, • Deliver evidence-based • Enhance go-to-market strategies targeting specific specialties and educati
Slide 7: Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies
Innovation Pipeline To Drive Improved Patient Outcomes And Workflow Efficiencies1 Recent Near Term Future Launches Launches Launches FastPrep With Recothrom Tisseel FLOW COUPLER Monitor Ready-To-Use Fibrin With Mobile App Sealant 100+ Geographic ~70 Geographic ~15 Geographic Expansions & Launches Ex
Slide 8: Poised To Make A Disruptive Impact
Poised To Make A Disruptive Impact Transformational Blood Management • Combine acquired technologies with internal capabilities to establish new paradigms for intraoperative blood management Untapped Opportunities • Serve more patients in underpenetrated segments through education, product developme
Slide 9: Baxter 2022 Investor Conference
Baxter 2022 Investor Conference Wigs ee,
Baxter International — Baxter's 2022 Investor Conference on 6ix